- Trust us, these “public trust” global warming cases aren’t going to succeed (Consumer Class Action and Mass Torts)
- Short and long-term implications of Supreme Court’s generic drug preemption ruling (FDA Law Blog)
- Supreme Court dissent invokes, majority shoots down, specter of Lochner v. New York in IMS Health opinions (Josh Blackman’s Blog)
- How IMS Health, a case that wasn’t about privacy, could impact health privacy protections (Tech Liberation Front)
- House of Representatives brings U.S. one step closer to actual patent law reform (Patent Baristas)
- If an employee pays a bribe out of his own pocket to a “foreign official,” is the company on the hook for corrupt practices violation? (FCPA Blog)
